PUBLISHER: The Business Research Company | PRODUCT CODE: 1951709
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951709
Digestive enzymes are compounds that assist in digestion by promoting the breakdown of food. These proteins accelerate the chemical reactions that transform food into substances that the digestive tract can absorb. They are produced and secreted by the salivary glands, as well as by the cells lining the stomach, pancreas, and small intestine.
The main categories of digestive enzymes include carbohydrates, protease, lipase, and other enzyme types. Lipase is a protein secreted by the pancreas, a small organ located near the stomach, which aids in the digestion of fats. These enzymes are sourced from animals, fungi, microbes, and plants and are used for treating indigestion, chronic pancreatitis, irritable bowel syndrome, and other conditions. The various distribution channels include retail outlets and online platforms.
Tariffs have created both cost pressures and supply chain shifts in the digestive enzymes market by increasing the prices of imported microbial strains, fermentation equipment, and active enzyme ingredients. These impacts are most strongly felt across fungal and microbial enzyme segments as well as in Asia-Pacific and North America, where a large share of enzyme production and pharmaceutical formulation takes place. Higher input costs have affected pricing for indigestion, chronic pancreatitis, and irritable bowel syndrome treatments distributed through both retail and online channels. However, tariffs have also encouraged local manufacturing and sourcing of plant- and animal-based enzymes, supporting domestic production and strengthening regional supply chains.
The digestive enzymes market research report is one of a series of new reports from The Business Research Company that provides digestive enzymes market statistics, including digestive enzymes industry global market size, regional shares, competitors with a digestive enzymes market share, detailed digestive enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the digestive enzymes industry. This digestive enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The digestive enzymes market size has grown rapidly in recent years. It will grow from $1.19 billion in 2025 to $1.34 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to growing prevalence of digestive disorders, increasing awareness of enzyme therapy, rising aging population, expansion of pharmaceutical enzyme formulations, growth of retail pharmacy networks.
The digestive enzymes market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising demand for personalized digestive solutions, increasing focus on gut health, growth of plant-based enzyme production, expansion of online health product sales, innovation in enzyme formulation technologies. Major trends in the forecast period include rising use of enzyme supplements for digestive health, growing demand for plant-based and microbial enzymes, increasing adoption of over-the-counter digestive aids, expansion of enzyme applications in chronic digestive disorders, growth of online distribution for digestive enzyme products.
The rising occurrence of gastrointestinal disorders across different age groups is fueling the growth of the digestive enzymes market. Gastrointestinal disorders include conditions that impact the gastrointestinal tract, such as the mouth, esophagus, stomach, small intestine, large intestine, and anus, often resulting from a lack of digestive enzymes. The increasing frequency of these disorders is linked to factors such as smoking, diet and genetics, sanitation, greater use of antibiotics, and environmental changes associated with industrialization and urbanization. For instance, in September 2025, the UK Health Security Agency (UKHSA), a government body in the UK responsible for health security in England, reported that laboratory-confirmed cases of Campylobacter, a pathogen that causes gastrointestinal infections, rose by 27.0 percent per 100,000 population, increasing from 96.1 in 2022 to 122.0 in 2024. As a result, the growing prevalence of digestive disorders supports the expansion of the digestive enzymes market.
Major companies in the digestive enzymes market are focusing on creating innovative solutions, such as enzymatic digestibility enhancers, to meet the increasing consumer preference for healthier options. An enzymatic digestibility enhancer is a substance or supplement containing enzymes specifically designed to improve the breakdown and absorption of nutrients in food. For instance, in September 2023, Huvepharma EOOD, a pharmaceutical company headquartered in Bulgaria, launched its enzymatic digestibility enhancer, Huvezym neXo, in the European Union, aiming to improve feed efficiency in growing poultry. This product, part of the Huvezym range, includes a complex of enzymes that boost nutrient absorption by lowering intestinal viscosity, de-encapsulating nutrients, and releasing prebiotic oligosaccharides. Research has shown that Huvezym neXo can increase growth rates by 4.4% and improve feed conversion by 3.5%.
In January 2024, Novozymes, a Denmark-based enzyme and microbial technology company, partnered with Chr. Hansen to complete a statutory merger and form Novonesis. Through this collaboration, Novonesis intends to expand its portfolio of digestive enzymes and health biosolutions by combining Novozymes' enzyme production capabilities with Chr. Hansen's microbial and fermentation expertise, enabling the development of innovative, biologically derived therapeutic and nutritional solutions. This initiative allows Novonesis to offer a comprehensive range of biosolutions across food, human health, and industrial applications, strengthening its position in the global digestive enzymes and enzyme-based health markets. Chr. Hansen is a Denmark-based bioscience company, focusing on digestive enzymes and culture supplies.
Major companies operating in the digestive enzymes market are Garden of Life LLC, Biotics Research Corporation, Klaire Laboratories, Abbott Nutrition, Amway Corporation, Food State Inc., Matsun Nutrition, Metagenics Inc., Twinlab Corporation, AST Enzymes, Vemo Corp., Advanced Vital Enzymes Pvt. Ltd., Zeus Biotech Limited, Vox Nutrition Inc., Enzyme Bioscience Pvt. Ltd., XYMOGEN Inc., Douglas Laboratories, Thorne Research Inc., Integrative Therapeutics LLC, Pure Encapsulations Inc., Ortho Molecular Products Inc., Designs for Health Inc., Master Supplements Inc., Proteozymes Pvt Ltd., Chr. Hansen Holding A/S, DSM Nutritional Products AG, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Nestle S.A., Pfizer Inc., Sanofi S.A., Specialty Enzymes & Biotechnologies Co.
North America was the largest region in the digestive enzymes market in 2025. Middle East is expected to be the largest growing region in the digestive enzymes market report during the forecast period. The regions covered in the digestive enzymes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digestive enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digestive enzymes market consists of sales of amylase, maltase, and lactase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digestive Enzymes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses digestive enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for digestive enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digestive enzymes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.